» Articles » PMID: 18313197

Saliva Variations in Gastro-oesophageal Reflux Disease

Overview
Journal J Dent
Publisher Elsevier
Specialty Dentistry
Date 2008 Mar 4
PMID 18313197
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The protective role of saliva in the case of oesophageal exposition to gastric acid has long been studied but some contradictions still remain. The main end-point of this study was to evaluate if a qualitative and quantitative alteration in salivary secretion exists in patients affected by GERD.

Methods: One hundred and twenty patients (T group) with clinically and endoscopically diagnosed GERD, and 98 healthy subjects (C group) have been evaluated; salivary tests (i.e. basal flow rate, stimulated flow rate, pH, [Na(+)] and [K(+)]) were performed, socio-demographical variables and oral GERD-related symptoms were taken into account. SPSS 10.5 software was used for statistical univariate and multivariate analyses.

Results: GERD patients and controls were found to have a similar basal flow rate but different stimulated salivary function [T group mean value 0.989 ml/min (+/-0.48718) vs. C group 1.2197 ml/min (+/-0.6108), pH [T group mean value 8.935 (+/-0.471) vs. C group 7.879 (+/-0.526)] and a higher K(+) concentration. In GERD patients we also registered a significant association with xerostomia [69/120 (57.5%) vs. 28/98 (28.7%)] and an oral burning sensation [58/120 (48.3%) vs. 19/98 (19.3%)].

Conclusions: Our findings assess that salivary secretion is altered in GERD patients and highlight the need for further investigations in order to define the role of saliva in the etiopathogenesis of GERD.

Citing Articles

Xerogenic medications may contribute to decreased unstimulated salivary flow in patients with oral burning and/or gastro-esophageal reflux disease.

Sangalli L, Eldomiaty W, Miller C Front Dent Med. 2025; 4:1047235.

PMID: 39916932 PMC: 11797851. DOI: 10.3389/fdmed.2023.1047235.


Usefulness of pepsin saliva measurement for the detection of primary burning mouth syndrome related to reflux.

Lechien J, Bobin F, Vaira L Eur Arch Otorhinolaryngol. 2023; 281(2):827-833.

PMID: 37906367 DOI: 10.1007/s00405-023-08317-x.


Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors.

Lim A, Talley N, Walker M, Storm G, Hua S Drug Deliv. 2023; 30(1):2219423.

PMID: 37344759 PMC: 10286676. DOI: 10.1080/10717544.2023.2219423.


Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update.

Durazzo M, Lupi G, Cicerchia F, Ferro A, Barutta F, Beccuti G J Clin Med. 2020; 9(8).

PMID: 32784573 PMC: 7465150. DOI: 10.3390/jcm9082559.


Associations between tooth wear and dental sleep disorders: A narrative overview.

Wetselaar P, Manfredini D, Ahlberg J, Johansson A, Aarab G, Papagianni C J Oral Rehabil. 2019; 46(8):765-775.

PMID: 31038764 PMC: 6852513. DOI: 10.1111/joor.12807.